Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label ADME study of oral SLV337 and 14C-SLV337
NL-OMON34267Active, not recruiting
- Sponsor
- Fournier
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of SLV337 in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Fournier. Primary endpoints: Relative bioavailability of SLV337 suspension versus capsules, Dose selection for Part 2 and 3 more. Started Jul 2010; status: active, not recruiting.
02
Drugs
SLV337
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON34267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34267.